Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-02-22 @ 7:25 AM
Study NCT ID:
NCT05194293
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-04
First Post:
2021-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
Sponsor:
Organization: